FLASH AGRI ZONE ALENA - FEV 2013 - Débats sur le saumon génétiquement modifié aux Etats-Unis. FDA 25/08/10 Environmental Assessment for AquAdvantage® Salmon. FDA 27/08/10 An overview of Atlantic salmon, its natural history, aquaculture, and genetic engineering. Section 1: Introduction - Salmon Section 2: Fish Consumption in the United States.
FDA 20/09/10 VMAC Briefing Packet - AquAdvantage Salmon. MERID 28/09/10 Audition de la F.D.A. axée sur l’étiquetage du saumon génétiquement modifié. Audition de la F.D.A. axée sur l’étiquetage du saumon génétiquement modifié Résumé posté par Meridian le 9/28/2010 Source: New York Times Auteur(s): Andrew Pollack Des groupes consuméristes et écologistes veulent que le saumon génétiquement modifié (GM) soit étiqueté GM, s’il est approuvé pour la consommation humaine aux Etats-Unis.
Toutefois, indique l’article, la Food and Drug Administration (FDA), qui est l’agence américaine de réglementation des aliments et des drogues, déclare qu’une telle étiquette risque de ne pas être possible selon sa réglementation. 20MINUTES 21/03/13 Etats-Unis: Les supermarchés ne veulent pas de saumon OGM. GMO COMPASS 23/09/10 USA: Dispute over the approval of genetically modified salmon. (23 September 2010) The possible approval of genetically modified salmon has led to vigorous dispute in the USA.
The recommendation by experts that that further testing be conducted for the time being was the conclusion of a hearing arranged by the American Food and Drug Administration (FDA) and echoed broadly in the media. The salmon would have been the first genetically modified animal approved for human consumption. The GM salmon (known under the brand name AquAdvantage) is exactly as safe as other salmon types, according to the results of a recently concluded safety assessment by the FDA.
In its material composition, foodstuff derived from the salmon in question was indistinguishable from conventional salmon products. According to the same report, the possible endangerment of wild salmon could be ignored since the GM salmon would be kept exclusively in farms at great distances to coastal regions. Allergy risk. AquaBounty applied for approval already in 1995. See also on GMO Compass: FOOD NAVIGATOR 30/09/10 GM salmon assessment ‘inappropriate’, say Senators.
Eleven US Senators have signed a letter to FDA Commissioner Margaret Hamburg urging the agency to find another way to assess the safety of genetically engineered (GE) salmon.
The fish, developed by Massachusetts-based AquaBounty Technologies, is Atlantic salmon given the growth hormone gene of the faster-growing Pacific salmon, along with DNA from the eel-like ocean pout. The company claims that the resulting AquAvantage salmon reaches maturity at twice the rate of normal Atlantic salmon, and requires 25 percent less food. This is the first time that the Food and Drug Administration (FDA) has considered the safety of genetic engineering in animals intended for human consumption, and it has no specific framework for doing so. AVMA 01/11/10 FDA considering approval of genetically engineered salmon - Veterinarians, consumer advocates raise concerns over.
Veterinarians, consumer advocates raise concerns over data By Greg Cima Posted Oct. 18, 2010 Both of these Atlantic salmon are 18 months old.
The larger fish is an AquAdvantage salmon, which has been genetically modified to grow more quickly than conventionally spawned Atlantic salmon. Some veterinarians and consumer advocates have recommended that the Food and Drug Administration require more data before deciding whether to allow a company to sell genetically engineered salmon in the U.S. Several veterinarians who serve on the FDA Veterinary Medicine Advisory Committee, which is examining the issue, said in late September they found information gaps and flaws in some studies of the fish, but some expect and hope the salmon eventually will be sold in grocery stores.
AquaBounty Technologies produces the modified Atlantic salmon, also known as AquAdvantage salmon, by incorporating an rDNA construct with gene-coding sequences from ocean pout and Chinook salmon. Dr. But Dr. Dr. Dr. Dr. Dr. Dr. FDA 04/05/12 AquAdvantage® Salmon - Draft Environmental Assessment. FDA 04/05/12 For public comment : FINDING OF NO SIGNIFICANT IMPACT AquAdvantage® Salmon. AP 26/03/13 Alaska Legislature passes resolution on genetically modified salmon. JUNEAU, Alaska — The Alaska Legislature has passed a resolution calling upon the U.S.
Food and Drug Administration to further investigate the effects of producing genetically engineered salmon. HJR5, by Rep. Geran Tarr of Anchorage, also asks the federal government to require labeling genetically modified salmon if it is to be sold. The Senate unanimously passed the resolution on Monday. It passed the House unanimously last month. The resolution is in line with concerns that have been raised by Alaska's congressional delegation. FDA has released a draft finding that a genetically modified salmon that grows twice as fast as normal is unlikely to harm the environment. THE CORNUCOPIA INSTITUTE 09/01/13 Action Alert: Genetically Engineered Salmon - FDA Seeks Public Comment - Comments due February. (This Action Alert is Over) FDA Seeks Public Comment UPDATE: The FDA has extended the comment deadline to April 26!
FDA poised to approve genetically engineered salmon despite unknown risks to human health. Inevitable accidental release of transgenic fish into the wild could devastate native fish populations and ecosystems! FRIENDS OF THE EARTH 21/12/12 “Fatally flawed” FDA assessment to unleash genetically engineered salmon. ShareThis Posted Dec. 21, 2012 / Posted by: Adam Russell Obama administration's final assessment last step before final approval of 'frankenfish' WASHINGTON, D.C. — Today, the Food and Drug Administration released its final environmental assessment on the so-called “frankenfish,” a salmon that has been genetically engineered by Massachusetts-based AquaBounty Technologies Inc.
(ABTX:LSE). This would be the first-ever genetically engineered animal intended for human consumption to enter the marketplace despite widespread public outcry and a faulty assessment based on incomplete company data. “It’s clear that the public doesn’t want to eat genetically engineered fish, and the FDA’s assessment is fatally flawed and fails to take into account the very real risk that these fish pose to the environment, public health and fishing communities on both coasts,” said Eric Hoffman, food and technology policy campaigner for Friends of the Earth. Categories: Food and Technology, News Releases.
FOOD SAFETY NEWS 04/03/14 Kroger, Safeway Will Nix GMO Salmon Regardless of FDA Decision. Kroger and Safeway, the largest retail grocery companies in the U.S., have reportedly agreed not to sell genetically modified salmon.
The decision was released Monday by a coalition of food safety, consumer, health and fishing groups. GREEN ET VERT 02/02/13 Le saumon OGM: la FDA évalue les risques environnementaux. USA / / Amérique du nord La société de biotechnologie Aquabounty cherche à produire et commercialiser un saumon génétiquement modifié.
La FDA pourrait l’autoriser. Du saumon génétiquement modifié dans nos assiettes ? Les saumons génétiquement modifiés se rapprochent du marché puisqu’après une évaluation des risques environnementaux, la FDA (Food and Drug Administration) a publié un avis favorable à la commercialisation de ces premiers poissons OGM. Depuis près de 17 ans, l’entreprise AquaBounty cherche à obtenir cet accord. Selon la FDA, le poisson génétiquement modifié, produit par la firme originaire du Massachusetts, ne représente aucune menace significative. La dernière évaluation portait sur des questions environnementales. Son élevage ? Contrairement au saumon d’élevage classique, les poissons ne seraient pas élevés dans des parcs dans l’océan mais dans des installations terrestres. Et l’étiquetage ? Et après?